Oramed Pharmaceuticals
ORMP
#9147
Rank
S$0.21 B
Marketcap
S$5.03
Share price
5.12%
Change (1 day)
65.36%
Change (1 year)

EPS for Oramed Pharmaceuticals (ORMP)

EPS in 2026 (TTM): S$5.57

According to Oramed Pharmaceuticals's latest financial reports the company's current EPS (TTM) is S$5.57. In 2025 the company made an earnings per share (EPS) of S$1.97 an increase over its 2024 EPS that were of S-$0.62.

EPS history for Oramed Pharmaceuticals from 2005 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S$5.57182.46%
2025S$1.97-418.75%
2024S-$0.62-442.86%
2023S$0.18-114.89%
2022S-$1.2120.51%
2021S-$1.0139.29%
2020S-$0.72-31.71%
2019S-$1.06-4.65%
2018S-$1.118.86%
2017S-$1.02-9.2%
2016S-$1.1229.85%
2015S-$0.868.06%
2014S-$0.805.08%
2013S-$0.763.51%
2012S-$0.73137.5%
2011S-$0.31-60%
2010S-$0.77-0%
2009S-$0.77-16.67%
2008S-$0.93-25%
2007S-$1.24700%
2006S-$0.15303.56%
2005S-$0.03832

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novo Nordisk
NVO
S$5.09-8.66%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
S$2.55-54.15%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
S-$6.69-220.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
S-$0.18-103.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
S$0.49-91.20%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel